ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,628.04
      0.22%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Invivyd Inc (IVVD)

      7. Invivyd Inc (IVVD) News

      IVVD

      Invivyd (IVVD)

      Invivyd Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IVVD
      DateTimeSourceHeadlineSymbolCompany
      05/31/20247:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
      05/31/20247:05AMGlobeNewswire Inc.Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authorization Pathway for the Prevention and Treatment of Symptomatic COVID-19, Based on Compact Clinical Programs to Establish Safety and Immunobridging for SerialNASDAQ:IVVDInvivyd Inc
      05/31/20247:00AMGlobeNewswire Inc.Invivyd Announces the Appointment of Timothy Lee as Chief Commercial OfficerNASDAQ:IVVDInvivyd Inc
      05/29/20247:00AMGlobeNewswire Inc.Invivyd to Present Data at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and 2024 American Transplant Congress (ATC)NASDAQ:IVVDInvivyd Inc
      05/23/20246:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
      05/23/20246:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
      05/23/20245:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
      05/23/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
      05/23/20244:50PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
      05/22/20247:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
      05/22/20247:00AMGlobeNewswire Inc.Invivyd Elects Two New Independent Members to its Board of DirectorsNASDAQ:IVVDInvivyd Inc
      05/16/20244:11PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IVVDInvivyd Inc
      05/13/20244:01PMGlobeNewswire Inc.Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:IVVDInvivyd Inc
      05/09/20244:32PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IVVDInvivyd Inc
      05/09/20244:20PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IVVDInvivyd Inc
      05/09/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
      05/09/20244:01PMGlobeNewswire Inc.Invivyd Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:IVVDInvivyd Inc
      05/07/20247:38AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
      05/07/20247:30AMGlobeNewswire Inc.Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA FeedbackNASDAQ:IVVDInvivyd Inc
      05/02/20245:13PMGlobeNewswire Inc.Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business HighlightsNASDAQ:IVVDInvivyd Inc
      04/30/20247:30AMGlobeNewswire Inc.Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash PositionNASDAQ:IVVDInvivyd Inc
      04/15/20247:30AMGlobeNewswire Inc.Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™NASDAQ:IVVDInvivyd Inc
      04/12/20247:30AMGlobeNewswire Inc.Invivyd Announces CEO TransitionNASDAQ:IVVDInvivyd Inc
      04/04/20244:01PMGlobeNewswire Inc.Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 MillionNASDAQ:IVVDInvivyd Inc
      03/28/20247:00AMGlobeNewswire Inc.Invivyd Reports Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:IVVDInvivyd Inc
      03/22/20243:28PMGlobeNewswire Inc.Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical TrialNASDAQ:IVVDInvivyd Inc
      03/22/20243:04PMGlobeNewswire Inc.Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19NASDAQ:IVVDInvivyd Inc
      02/12/20244:01PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:IVVDInvivyd Inc
      02/09/20244:47PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IVVDInvivyd Inc
      02/09/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
       Showing the most relevant articles for your search:NASDAQ:IVVD